Posted by Michael Wonder on 08 Jun 2021
Alpha Tau receives breakthrough device designation from the FDA for Alpha DaRT
8 June 2021 - Alpha Tau Medical is pleased to announce that it has received a breakthrough device designation for Alpha DaRT from the U.S. FDA.
This designation applies to the treatment of squamous cell carcinoma of the skin and oral cavity without curative standard of care.
